No abstract available
MeSH terms
-
Anti-HIV Agents / economics*
-
Cost-Benefit Analysis
-
Developing Countries
-
Female
-
HIV Infections / drug therapy
-
HIV Infections / economics*
-
HIV-1 / drug effects
-
Health Priorities
-
Humans
-
Male
-
Public Health / economics*
-
Viral Load / economics*